Hooman Nakysa, Esfahani Seyed-Taher, Mohkam Masoumeh, Derakhshan Ali, Gheissari Alaleh, Vazirian Shams, Mortazavi Fakhrossadat, Ghane-Sherbaff Fatemeh, Falak-Aflaki Behnaz, Otoukesh Hasan, Madani Abbas, Sharifian-Dorcheh Mostafa, Mahdavi Ali, Esmaeile Mohamad, Naseri Mitra, Azhir Afshin, Merikhi Alireza, Mohseni Parvin, Ataei Neamatollah, Fallahzadeh Mohamad-Hossein, Basiratnia Mitra, Hosseini-Al-Hashemi Ghamar
Department of Pediatric Nephrology, Ali Asgar Children's Hospital, Iran University of Medical Sciences, Tehran, Iran.
Arch Iran Med. 2009 Jan;12(1):24-8.
Continuous ambulatory peritoneal dialysis is not a very common modality to treat Iranian children with end-stage renal disease; however, there is sometimes no choice but to offer this therapy to salvage the patient. Obviously, promotion in each program needs re-evaluation to find the pitfalls. Therefore, a nation-wide survey on pediatric continuous ambulatory peritoneal dialysis was conducted to find the cause of death or termination of dialysis.
All children, younger than 14 years old, treated by continuous ambulatory peritoneal dialysis in nine main pediatric nephrology wards in Iran between 1993 and 2006 were included in this historical cohort study. Patient and technique survival rates were determined. Kaplan-Mayer and Cox-regression analysis were used to compare the survival. 2 x 2 table was used to calculate the risk ratio. A P<0.05 was considered significant.
One hundred twenty children with a mean age of 47.6 months were on continuous ambulatory peritoneal dialysis. The most frequent cause of renal failure was hereditary-metabolic-cystic disease. One hundred eighty-two peritoneal dialysis catheters were inserted surgically. The median first catheter exchange was 0.74 year (95%CI: 0.5 - 0.98). The most frequent cause of catheter replacement was catheter outflow failure due to displacement, adhesion, and infection (persistent peritonitis or tunnel infection). The mean patient survival was 1.22 years (95%CI: 0.91 - 1.53). The mortality rate was 55% before 1997, and 60% between 1998 and 2001, which declined to 23% after 2002 (P<0.05). Young age (<24 months) was the only independent factor that predicted mortality (P<0.05). The outcome of children was as follows: recovery of renal function (6.7%), renal transplantation (8.3%), switch to hemodialysis (16.7%), still on continuous ambulatory peritoneal dialysis (23.3%), death (43.3%), and lost to follow-up (1.7%).
The mortality is still high among Iranian children on peritoneal dialysis. Young age is the most important factor influencing on survival and mortality.
持续性非卧床腹膜透析并非治疗伊朗终末期肾病儿童的常见方式;然而,有时为挽救患者别无选择,只能采用这种治疗方法。显然,每个项目都需要重新评估以发现其中的问题。因此,开展了一项关于儿童持续性非卧床腹膜透析的全国性调查,以找出死亡或透析终止的原因。
本历史队列研究纳入了1993年至2006年间在伊朗9个主要儿科肾脏病病房接受持续性非卧床腹膜透析治疗的所有14岁以下儿童。确定患者生存率和技术生存率。采用Kaplan - Mayer法和Cox回归分析比较生存率。使用2×2列联表计算风险比。P<0.05被认为具有统计学意义。
120名平均年龄为47.6个月的儿童接受持续性非卧床腹膜透析。肾衰竭最常见的原因是遗传性 - 代谢性 - 囊性疾病。手术植入了182根腹膜透析导管。首次导管更换的中位数为0.74年(95%置信区间:0.5 - 0.98)。导管更换最常见的原因是由于移位、粘连和感染(持续性腹膜炎或隧道感染)导致的导管引流失败。患者平均生存时间为1.22年(95%置信区间:0.91 - 1.53)。1997年前死亡率为55%,1998年至2001年间为60%,2002年后降至23%(P<0.05)。低龄(<24个月)是预测死亡率的唯一独立因素(P<0.05)。儿童的结局如下:肾功能恢复(6.7%)、肾移植(8.3%)、转为血液透析(16.7%)、仍接受持续性非卧床腹膜透析(23.3%)、死亡(43.3%)和失访(1.7%)。
伊朗接受腹膜透析的儿童死亡率仍然很高。低龄是影响生存和死亡的最重要因素。